-
公开(公告)号:US20190269853A1
公开(公告)日:2019-09-05
申请号:US16417885
申请日:2019-05-21
Applicant: Covidien LP
Inventor: Peter Doyle , Paul S. Addison , James N. Watson
IPC: A61M5/172 , A61B5/00 , A61B5/08 , A61B5/1455
Abstract: Methods and systems are provided for determining fluid administration. The system may determine fluid administration based on the fluid responsiveness and regional oxygen saturation of a subject. The system may receive the fluid responsiveness and regional oxygen saturation from external sources or may determine one or both based on received physiological signals. In some embodiments, the system may determine whether to administer fluid based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the amount of fluid to administer based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the effectiveness of fluid administration. In some embodiments, the system may provide an indication of the determined fluid administration so that a care-giver can implement the appropriate fluid administration. In some embodiments, the system may control the fluid administration based on its determination.
-
公开(公告)号:US10328202B2
公开(公告)日:2019-06-25
申请号:US15006018
申请日:2016-01-25
Applicant: Covidien LP
Inventor: Peter Doyle , Paul S. Addison , James N. Watson
IPC: A61M5/172 , A61B5/08 , A61B5/1455 , A61B5/00 , A61B5/024
Abstract: Methods and systems are provided for determining fluid administration. The system may determine fluid administration based on the fluid responsiveness and regional oxygen saturation of a subject. The system may receive the fluid responsiveness and regional oxygen saturation from external sources or may determine one or both based on received physiological signals. In some embodiments, the system may determine whether to administer fluid based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the amount of fluid to administer based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the effectiveness of fluid administration. In some embodiments, the system may provide an indication of the determined fluid administration so that a care-giver can implement the appropriate fluid administration. In some embodiments, the system may control the fluid administration based on its determination.
-
公开(公告)号:US10299734B2
公开(公告)日:2019-05-28
申请号:US15281561
申请日:2016-09-30
Applicant: COVIDIEN LP
Inventor: James N. Watson , Daniel Bartlett , Paul S. Addison
IPC: A61B5/0205 , A61B5/00 , A61B5/1455 , A61B5/024 , A61B5/08 , A61B5/11
Abstract: A system may include a photoplethysmograph (PPG) sensor configured to be secured to a patient and to generate a PPG signal for the patient. The system may also include a motion sensor configured to generate a motion signal indicative of motion of the patient. Further, the system may include a controller configured to receive the PPG signal from the PPG sensor and the motion signal from the motion sensor, to analyze the motion signal to detect motion of the patient, and to deactivate the at least one emitter of the PPG sensor based on the analysis of the motion signal when motion of the patient is detected.
-
公开(公告)号:US10292663B2
公开(公告)日:2019-05-21
申请号:US15194122
申请日:2016-06-27
Applicant: COVIDIEN LP
Inventor: Paul S. Addison , James N. Watson
IPC: A61B5/00 , A61B5/021 , A61B5/1455 , A61B5/0205 , A61B5/0225 , A61B5/0285 , A61B5/022 , A61B5/024 , G16H50/30 , G16H50/50
Abstract: A method for monitoring autoregulation includes receiving a blood pressure signal and an oxygen saturation signal, determining a phase difference between the blood pressure signal and the oxygen saturation signal, and determining a patient's autoregulation status based at least in part on a phase difference between the blood pressure signal and the oxygen saturation signal.
-
公开(公告)号:US20180177463A1
公开(公告)日:2018-06-28
申请号:US15903009
申请日:2018-02-22
Applicant: Covidien LP
Inventor: Paul S. Addison , James Wolstencroft , James Watson
IPC: A61B5/00 , A61B5/0295 , A61B5/08 , A61B5/0205 , A61B5/113 , A61B5/083 , A61B5/1455
CPC classification number: A61B5/7275 , A61B5/0205 , A61B5/0295 , A61B5/0816 , A61B5/0823 , A61B5/0836 , A61B5/113 , A61B5/14551 , A61B5/7207 , A61B5/7221 , A61B5/7278 , A61B5/742 , A61B5/743 , A61B5/746
Abstract: Methods and systems are provided that determine whether a patient is breathing irregularly. A system may receive a physiological signal, such as a plethysmographic signal or an end-tidal carbon dioxide signal, from a sensor. The system may analyze the signal for one or more features indicative of irregular breathing, which may be a result of a patient talking, moving, yawning, coughing, sneezing, or the like. The system may also be configured to provide an indication of the irregular breathing.
-
86.
公开(公告)号:US20180158550A1
公开(公告)日:2018-06-07
申请号:US15888328
申请日:2018-02-05
Applicant: Covidien LP
Inventor: James Watson , Paul S. Addison , Keith Manning
CPC classification number: G16H40/63 , A61B5/021 , A61B5/02416 , A61B5/14551 , A61B5/746 , A61B2560/0223 , G16H50/20
Abstract: Methods and systems are presented for indicating the proximity of a process requirement metric to a corresponding system process requirement in a physiological monitor. Metrics are determined based on a received physiological signal, such as a PPG signal. At least one of the metrics is compared to a corresponding system process requirement, such as a threshold, which can be used to trigger a system process, such as an alarm, a recalibration, or a measurement. The proximity of the metric to the corresponding system process requirement is calculated and indicated. Indicating the proximity to a system process requirement may provide valuable information to clinicians and allow them to manually trigger system processes, such as measurements or recalibrations, when a metric is close to a system process requirement for a significant period of time.
-
公开(公告)号:US09955894B2
公开(公告)日:2018-05-01
申请号:US14606943
申请日:2015-01-27
Applicant: Covidien LP
Inventor: Paul S. Addison , James N. Watson
IPC: A61B5/04 , A61B5/0476 , A61B5/00
CPC classification number: A61B5/0476 , A61B5/4821 , A61B5/726
Abstract: Methods and systems are presented for determining physiological information in a physiological monitor. A physiological signal (e.g., an EEG signal) received from a subject is wavelet transformed and first and second related features that vary in scale over time are identified in the transformed signal. First and second coupled ridges of the respective first and second related features may also be identified in the transformed signal. A non-stationary relationship parameter is determined and is indicative of the relationship between the first and second features and/or between the first and second ridges. Physiological information, which may be indicative of a level of awareness of a subject, is determined based on the non-stationary relationship parameter. This physiological information may be used, for example, in an operating room to monitor/regulate the subject's anesthetic state while under general anesthesia or in an intensive care unit to monitor the subject's sedateness and administer medication accordingly.
-
公开(公告)号:US20180014791A1
公开(公告)日:2018-01-18
申请号:US15648665
申请日:2017-07-13
Applicant: COVIDIEN LP
Inventor: Dean Montgomery , Paul S. Addison , Peter Galen
IPC: A61B5/00 , A61B5/1455 , A61B5/021
CPC classification number: A61B5/7275 , A61B5/021 , A61B5/14551 , A61B5/14553 , A61B5/4064 , A61B5/7246 , G16H50/30
Abstract: A system for monitoring autoregulation includes an oxygen saturation sensor configured to obtain an oxygen saturation signal indicative of an oxygen saturation of a patient. The system also includes a controller having a processor configured to receive a blood pressure signal indicative of a blood pressure of the patient and the oxygen saturation signal, determine a change in the oxygen saturation signal and a change in the blood pressure signal over a period of time, and provide an indication that the patient's autoregulation is intact if the oxygen saturation changes by more than an oxygen saturation threshold and if the blood pressure changes by less than a blood pressure threshold during the period of time.
-
公开(公告)号:US20170196501A1
公开(公告)日:2017-07-13
申请号:US14993856
申请日:2016-01-12
Applicant: COVIDIEN LP
Inventor: James N. Watson , Paul S. Addison
IPC: A61B5/00 , A61B5/1455 , G06F19/00 , A61B5/0476
CPC classification number: A61B5/4821 , A61B5/0476 , A61B5/14551 , A61B5/7221 , G16H10/60 , G16H40/63 , G16H50/30
Abstract: A patient monitor for monitoring cerebral activity of a patient may include a processor configured to determine a depth of consciousness index for the patient based on electroencephalography (EEG) data and determine regional oxygen saturation for the patient based on regional oximetry data. Additionally, the processor may be configured to determine a metric associated with cerebral activity of the patient based at least in part on the one or more values of the depth of consciousness index and the one or more regional oxygen saturation values and to provide the one or more values of a depth of consciousness index and the metric to an output device.
-
公开(公告)号:US20170000395A1
公开(公告)日:2017-01-05
申请号:US15194098
申请日:2016-06-27
Applicant: COVIDIEN LP
Inventor: Paul S. Addison , James N. Watson
IPC: A61B5/1455 , A61B5/00 , A61B5/021
CPC classification number: A61B5/14553 , A61B5/021 , A61B5/02108 , A61B5/7221 , G06F19/00 , G16H50/20 , G16H50/50
Abstract: A method for monitoring autoregulation includes using a processor for receiving blood pressure data and oxygen saturation data from a patient, fitting a dynamic model to the blood pressure data and the oxygen saturation data to determine one or more parameters of the dynamic model indicative of autoregulation, and determining the patient's autoregulation status based on the one or more parameters.
Abstract translation: 一种用于监测自动调节的方法包括使用处理器从患者接收血压数据和氧饱和度数据,将动态模型拟合到血压数据和氧饱和度数据,以确定指示自动调节的动态模型的一个或多个参数, 以及基于所述一个或多个参数确定所述患者的自动调节状态。
-
-
-
-
-
-
-
-
-